Study of vitamin D levels in pediatric patients on antiepileptic monotherapy

Fahim Salam; Shabir Mohammad; Nehal Singhal; Suresh Kumar Verma; Ayush Verma

doi:10.18203/2349-3291.ijcp20260401

Authors

Fahim Salam Department of Paediatrics, Dr. S. N. Medical College Jodhpur, Rajasthan, India
Shabir Mohammad Department of Paediatrics, Government Medical College Pali, Rajasthan, India
Nehal Singhal Max Hospital Mohali, Chandigarh, India
Suresh Kumar Verma Department of Paediatrics, Dr. S. N. Medical College Jodhpur, Rajasthan, India
Ayush Verma Government Medical College, Barmer, Rajasthan, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20260401

Keywords:

Antiepileptic drug, Vitamin D levels, Monotherapy, Pediatric epilepsy patients, Levetiracetam

Abstract

Background: Epilepsy affects nearly 50 million people worldwide, with childhood onset common. Long-term antiepileptic drug (AED) therapy, including valproate (VPA), carbamazepine (CBZ), and levetiracetam (LEV), may adversely influence vitamin D metabolism, impacting bone and neurological health. With limited pediatric data and no supplementation guidelines, this study investigates the association between AED monotherapy, vitamin D status, and biochemical outcomes in children. The aim of this study is to evaluate if CBZ, VPA and LEV as monotherapy is associated with vitamin D deficiency among children with epilepsy.

Results: In 86 pediatric patients (52.3% female), VPA (43%) and CBZ (24.4%) significantly reduced Vitamin D3 to 22.7 ng/ml and calcium to 9.1 mg/dl at 6 months, while elevating ALP to 281.4 IU/L and 267.7 IU/L, respectively. LEV (32.6%) showed milder effects (28.7 ng/ml, 202.5 IU/L).

Methods: After ethics approval, children aged 5-18 years with epilepsy at Umaid/MDM Hospital were screened. Baseline serum vitamin D3, calcium, phosphate, and ALP were measured using chemiluminescence. Patients with normal vitamin D3 (>20 ng/ml) were enrolled and initiated on VPA, LEV, or CBZ, with follow-up monitoring for biochemical changes. Statistical tool used is SPSS v.22.

Conclusions: VPA and CBZ were associated with significant declines in vitamin D and calcium levels, along with elevated ALP, indicating adverse effects on bone health in pediatric epilepsy patients. LEV showed comparatively milder effects. Routine monitoring and proactive management of bone health are crucial for all children on long-term AED therapy.

Metrics

Metrics Loading ...

References

Fisher RS. The 2014 Definition of Epilepsy: A perspective for patients and caregivers. Int League Against Epilepsy. 2014.

World Health Organization. Epilepsy fact sheet. 2021. Available at: https://www.who.int/news-room/fact-sheets/detail/epilepsy. Accessed on 15 January 2025.

Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-81. DOI: https://doi.org/10.1056/NEJMra070553

Munns CF, Shaw N, Kiely M, Bonny LS, Tom DT, Keiichi O, et al. Global consensus recommendations on prevention and management of nutritional rickets. J Clin Endocrinol Metab. 2016;101(2):394-415. DOI: https://doi.org/10.1210/jc.2015-2175

Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academies Press. 2011. Available at: https://www.nap.edu/catalog/13050/dietary-reference-intakes-for-calcium-andvitamin-d. Accessed on 15 January 2025.

Tripathy KD. Medical Pharmacology 8th edition. Mechanisms of antiepileptic drugs. Suraj TC. India. 2024;440.

Junges C, Machado TD, Nunes Filho PRS, Riesgo R, Mello ED. Vitamin D deficiency in pediatric patients using antiepileptic drugs: systematic review with meta-analysis. J Pediatr (Rio J). 2020;96(5):559-68. DOI: https://doi.org/10.1016/j.jped.2020.01.004

Durá-Travé T, Gallinas-Victoriano F, Malumbres-Chacón M, MorenoGónzalez P, Aguilera-Albesa S, Yoldi-Petri ME. Vitamin D deficiency in children with epilepsy taking valproate and levetiracetam as monotherapy. Epilepsy Res. 2018;139:80-4. DOI: https://doi.org/10.1016/j.eplepsyres.2017.11.013

Chaudhuri JR, Mridula KR, Rathnakishore C, Balaraju B, Bandaru VS. Association of 25-hydroxyvitamin D deficiency in pediatric epileptic patients. Iran J Child Neurol. 2017;11(2):48-56.

Abdullah AT, Mousheer ZT. Vitamin D status in epileptic children on valproic acid; a case-control study. Arch Acad Emerg Med. 2020;8(1):e13.

Sreedharan M, Devadathan K, Mohammed Kunju PA, Sasidharan B, Pillai JP, Vasumathy Amma MA, Muthubeevi S. Vitamin D deficiency in ambulant children on carbamazepine or sodium valproate monotherapy. Indian Pediatr. 2018;55(4):307-10. DOI: https://doi.org/10.1007/s13312-018-1273-9

Iragamreddy VR, Rao P, Yadav R. Comparative analysis of vitamin D levels in children with epilepsy on antiepileptic drugs. Int J Contemp Pediatr. 2023;10(6):774-9. DOI: https://doi.org/10.18203/2349-3291.ijcp20231411

Vijayakumar M, Bk A, George B, Bhatia V. Vitamin D status in children on anticonvulsant therapy. Indian J Pediatr. 2022;89(6):541-5. DOI: https://doi.org/10.1007/s12098-021-03853-y